Venture Capital & Emerging Companies

In this week’s episode of Client Corner, Member and Host Josh Fox chats with Anna Turetsky, Principal, Venture Investments for the Mark Foundation for Cancer Research.

In this episode of Client Corner, Josh chats with Rahul Dhanda, co-founder and CEO of Syntis Bio, a late-stage, preclinical company developing a new class of therapy.

In this episode of Client Corner, Josh chats with John Edwards, an executive chair, board member, and senior adviser to start-up and clinical-stage biotechnology companies.

In this episode of Client Corner, Josh chats with Ridhi Tariyal, co-founder and CEO of NextGen Jane, a company that is defining the next generation of obstetric and gynecological health.

In this episode of Client Corner, Joshua Fox chats with Jerry Williamson, CEO of Sengenics. Jerry has more than 30 years of experience in bioscience markets for life science research, diagnostics, and analytical products.

Mintz welcomed investors and entrepreneurs from the Canadian and US life sciences ecosystem to our first annual matchmaking event in Toronto. In this video, hear about cross-border considerations for the sector and how Mintz’s life sciences focus positions us to guide emerging growth companies and investors doing business in both countries.

Generative artificial intelligence creates content and work efficiencies but also comes with legal pitfalls. Mintz Venture Capital & Emerging Companies Practice Co-chair Jeremy Glaser and Associate Lorena Niebla look at the technology's potential uses as well as risks related to data privacy, intellectual property, and more.